Functions of galectin-3 and its role in fibrotic diseases

208Citations
Citations of this article
184Readers
Mendeley users who have this article in their library.

Abstract

Fibrotic diseases occur in a variety of organs and lead to continuous organ injury, function decline, and even failure. Currently effective treatment options are limited. Galectin-3 (Gal-3) is a pleiotropic lectin that plays an important role in cell proliferation, adhesion, differentiation, angiogenesis, and apoptosis. Accumulating evidence indicates that Gal-3 activates a variety of profibrotic factors, promotes fibroblast proliferation and transformation, and mediates collagen production. Recent studies have defined key roles for Gal-3 in fibrogenesis in diverse organ systems, including liver, kidney, lung, and myocardial. To help set the stage for future research, we review recent advances about the role played by Gal-3 in fibrotic diseases. Herein we discuss the potential profibrotic role of Gal-3, inhibition of which may represent a promising therapeutic strategy against tissue fibrosis.

Cite

CITATION STYLE

APA

Li, L. C., Li, J., & Gao, J. (2014, November 1). Functions of galectin-3 and its role in fibrotic diseases. Journal of Pharmacology and Experimental Therapeutics. American Society for Pharmacology and Experimental Therapy. https://doi.org/10.1124/jpet.114.218370

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free